1
|
Diguisto C, Piver E, Gouge AL, Eboue F, Vaillant CL, Maréchaud M, Goua V, Giraudeau B, Perrotin F. First trimester uterine artery Doppler, sFlt-1 and PlGF to predict preeclampsia in a high-risk population. J Matern Fetal Neonatal Med 2017; 30:1514-1519. [DOI: 10.1080/14767058.2016.1183631] [Citation(s) in RCA: 9] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/21/2022]
Affiliation(s)
- Caroline Diguisto
- Department of Obstetrics, Gynecology and Fetal Medicine, University Hospital of Tours, 2 Boulevard Tonnellé, Tours Cedex 9, France
- Department of Medicine, University François Rabelais, Tours, France
| | - Eric Piver
- Department of Medicine, University François Rabelais, Tours, France
- Department of Biochemistry, University Hospital Tours, Tours, France
| | | | - Florence Eboue
- Department of Obstetrics, Gynecology and Fetal Medicine, University Hospital of Tours, 2 Boulevard Tonnellé, Tours Cedex 9, France
- Maternité Notre Dame de Bon Secours, Groupe Hospitalier Saint Joseph, Paris, France
| | | | - Martine Maréchaud
- Department of Obstetrics, University Hospital of Poitiers, Poitiers, France
| | - Valérie Goua
- Department of Obstetrics, University Hospital of Poitiers, Poitiers, France
| | - Bruno Giraudeau
- Department of Medicine, University François Rabelais, Tours, France
- INSERM CIC 1415, University Hospital Tours, Tours, France
| | - Franck Perrotin
- Department of Obstetrics, Gynecology and Fetal Medicine, University Hospital of Tours, 2 Boulevard Tonnellé, Tours Cedex 9, France
- Department of Medicine, University François Rabelais, Tours, France
| |
Collapse
|
2
|
Tessier A, Sarreau M, Pelluard F, André G, Blesson S, Bucourt M, Dechelotte P, Faivre L, Frébourg T, Goldenberg A, Goua V, Jeanne-Pasquier C, Guimiot F, Laquerriere A, Laurent N, Lefebvre M, Loget P, Maréchaud M, Mechler C, Perez MJ, Sabourin JC, Verloes A, Patrier S, Guerrot AM. Fraser syndrome: features suggestive of prenatal diagnosis in a review of 38 cases. Prenat Diagn 2016; 36:1270-1275. [PMID: 27859469 DOI: 10.1002/pd.4971] [Citation(s) in RCA: 19] [Impact Index Per Article: 2.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/07/2016] [Revised: 11/06/2016] [Accepted: 11/11/2016] [Indexed: 01/20/2023]
Abstract
OBJECTIVE Fraser syndrome (FS) is a rare malformation recessive disorder. Major criteria are cryptophtalmos, syndactyly, respiratory, genital and urinary tract anomalies. Few prenatal presentations have been reported. METHOD We analyzed the prenatal and postnatal fetal phenotype in 38 cases of FS, including 25 pregnancy termination cases, 8 intra-uterine death cases and 4 cases that died after birth. RESULTS Including both prenatal and postnatal fetal phenotypic evaluation, all cases presented dysmorphic features with nose and ear dysplasia. Renal anomalies and syndactyly were present in 37/38 cases, cryptophtalmos in 36/38, airways anomalies in 30/37 and genital anomalies in 30/35 cases. Anomalies of the abdominal wall such as low set umbilicus and omphalocele were found in 31 cases. Among the 26 cases for which ultrasound data were available, detectable anomalies included oligohydramnios (22), ascites/hydrops (9), renal anomalies (20), evidence for high airways obstruction (11), ophthalmologic anomalies (4), ear dysplasia (2) and syndactyly (2). CONCLUSION This study shows that the postnatal phenotype of FS is very specific, whereas oligohydramnios hampers the prenatal recognition of the cardinal FS diagnosis criteria. Association of oligohydramnios, kidney agenesis and CHAOS should lead to consider this diagnosis. © 2016 John Wiley & Sons, Ltd.
Collapse
Affiliation(s)
- Aude Tessier
- Department of Genetics, Rouen University Hospital and Inserm U1079, Faculty of Medicine, Normandy Centre for Genomic and Personalized Medicine, Rouen, France.,Department of Pathology, Rouen University Hospital, Rouen, France
| | - Mélie Sarreau
- Department of Gynecology and Obstetrics, Angoulême Hospital, Angoulême, France.,Prenatal Diagnosis Unit, Poitiers University Hospital, Poitiers, France
| | - Fanny Pelluard
- Department of Pathology, Bordeaux University Hospital, Bordeaux, France
| | - Gwenaelle André
- Department of Pathology, Bordeaux University Hospital, Bordeaux, France
| | - Sophie Blesson
- Department of Genetics, Bretonneau University Hospital, Tours, France
| | - Martine Bucourt
- Department of Pathology, Jean Verdier Hospital, APHP, Bondy, France
| | - Pierre Dechelotte
- Fetal Medicine Unit, Clermont-Ferrand University Hospital, Clermont-Ferrand, France
| | - Laurence Faivre
- Department of Genetics, FHU-TRANSLAD, University Hospital of Dijon, Dijon, France
| | - Thierry Frébourg
- Department of Genetics, Rouen University Hospital and Inserm U1079, Faculty of Medicine, Normandy Centre for Genomic and Personalized Medicine, Rouen, France
| | - Alice Goldenberg
- Department of Genetics, Rouen University Hospital and Inserm U1079, Faculty of Medicine, Normandy Centre for Genomic and Personalized Medicine, Rouen, France
| | - Valérie Goua
- Prenatal Diagnosis Unit, Poitiers University Hospital, Poitiers, France
| | | | - Fabien Guimiot
- Department of Developmental Biology, UMR1141, Robert Debré University Hospital and Paris Diderot University, Paris, France
| | | | - Nicole Laurent
- Department of Pathology, Dijon University Hospital, Dijon, France
| | - Mathilde Lefebvre
- Department of Genetics, FHU-TRANSLAD, University Hospital of Dijon, Dijon, France.,Department of Pathology, Dijon University Hospital, Dijon, France
| | - Philippe Loget
- Department of Pathology, Rennes University Hospital, Rennes, France
| | - Martine Maréchaud
- Prenatal Diagnosis Unit, Poitiers University Hospital, Poitiers, France
| | - Charlotte Mechler
- Department of Pathology, Louis Mourier Hospital, APHP, Colombes, France
| | - Marie-Josée Perez
- Department of Genetics, Montpellier Arnaud de Villeneuve University Hospital, Montpellier, France
| | | | - Alain Verloes
- Department of Genetics, Robert-Debré University Hospital, Paris, France
| | - Sophie Patrier
- Department of Pathology, Rouen University Hospital, Rouen, France
| | - Anne-Marie Guerrot
- Department of Genetics, Rouen University Hospital and Inserm U1079, Faculty of Medicine, Normandy Centre for Genomic and Personalized Medicine, Rouen, France
| |
Collapse
|
3
|
Allaf B, Dreux S, Schmitz T, Czerkiewicz I, Le Vaillant C, Benachi A, Houfflin-Debarge V, Maréchaud M, Oury JF, Muller F. Amniotic fluid biochemistry in isolated polyhydramnios: a series of 464 cases. Prenat Diagn 2015; 35:1331-5. [DOI: 10.1002/pd.4700] [Citation(s) in RCA: 13] [Impact Index Per Article: 1.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/07/2015] [Revised: 09/22/2015] [Accepted: 09/24/2015] [Indexed: 11/09/2022]
Affiliation(s)
- Bichr Allaf
- Biochimie-Hormonologie; Hôpital Robert Debré, APHP; Paris France
| | - Sophie Dreux
- Biochimie-Hormonologie; Hôpital Robert Debré, APHP; Paris France
| | - Thomas Schmitz
- Gynécologie-Obstétrique; Hôpital Robert Debré, APHP; Paris France
| | | | | | - Alexandra Benachi
- Gynécologie-Obstétrique et Médecine de la Reproduction, Hôpital Antoine Béclère, AP-HP; Université Paris Sud; Clamart France
| | | | | | | | - Françoise Muller
- Biochimie-Hormonologie; Hôpital Robert Debré, APHP; Paris France
- Université Versailles Saint Quentin en Yvelines; Versailles France
| |
Collapse
|
5
|
Bonneau D, Roume J, Gonzalez M, Toutain A, Carles D, Maréchaud M, Biran-Mucignat V, Amati P, Moraine C. Splenogonadal fusion limb defect syndrome: report of five new cases and review. Am J Med Genet 1999; 86:347-58. [PMID: 10494091 DOI: 10.1002/(sici)1096-8628(19991008)86:4<347::aid-ajmg9>3.0.co;2-a] [Citation(s) in RCA: 21] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 11/11/2022]
Abstract
Splenogonadal fusion (SGF) is a rare congenital malformation in which the spleen is abnormally connected to the gonad. SGF may occur as an isolated condition or may be associated with other malformations, especially with terminal limb defects in what is called splenogonadal fusion limb defect (SGFLD) syndrome. In this article, we report on 5 new cases of SGFLD and we review the 25 cases reported since 1889. Most cases reviewed here have a combination of severe limb and oro-mandibular defects, suggesting that SGFLD may be related to the broader group of Hanhart complex. In addition, several cases have limb malformations and facial anomalies, which suggest that SGFLD overlaps with both femur-fibula-ulna dysostosis and femoral-facial syndrome. The hypothesis of a vascular disruptive event, occurring between the 5th and the 7th weeks of gestation, could explain the limb defects, the mandibular hypoplasia, and the fusion of the spleen to the gonad observed in SGFLD. However, this heterogenous and polytopic condition could also be the consequence of a primary field defect. All the cases to date reported have been sporadic and the recurrence risk is probably low. However, a recent case of Roberts syndrome with SGF was reported that suggests careful examination of chromosomal status.
Collapse
Affiliation(s)
- D Bonneau
- Service de Génétique, CHU de Poitiers, Poitiers, France.
| | | | | | | | | | | | | | | | | |
Collapse
|
6
|
Abstract
We report on two sib fetuses, products of a consanguineous union, who had multiple and apparently unrelated malformations. The first fetus, a female, had trilobed lungs, a single cardiac ventricle, asplenia, situs ambiguus of the liver, and a lumbosacral meningomyelocele. The brain of this fetus was normal. The second fetus, a male, had bilobed lungs, a single cardiac ventricle, situs solitus of the abdominal organs and spleen, and a semilobar holoprosencephaly. The occurrence of these malformations in sibs of different sexes and the parental consanguinity suggest a recessive mutation in a gene responsible for both heterotaxy and midline defects, including holoprosencephaly.
Collapse
Affiliation(s)
- D Bonneau
- Service de Génétique, CHU de Poitiers, France.
| | | | | | | | | | | |
Collapse
|
7
|
Sarfati R, Maréchaud M, Magnin G. [Comparison of blood loss during cesarean section and during vaginal delivery with episiotomy]. J Gynecol Obstet Biol Reprod (Paris) 1999; 28:48-54. [PMID: 10394516] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 02/13/2023]
Abstract
OBJECTIVE The aim of our study was to compare blood loss during vaginal delivery with episiotomy and during cesarean section, to determine risk factors, and to determine whether clinical assessment of blood loss at delivery is well-evaluated. PATIENTS AND METHODS We retrospectively matched 97 vaginal deliveries with episiotomy with 97 cesarean deliveries which has occurred between 1 November 1991 and 30 April 1993. Matching criteria were age, parity, term and birth weight. Blood loss at delivery was defined by a drop in hematocrit greater than 10% between the pre-delivery anesthesia work-up and the laboratory results 3 days post-partum. RESULTS We found that hemoglobin and hematocrit fell more after vaginal deliveries than after cesarean section (p < 0.05 and p < 0.01). The fall in hemoglobin level and hematocrit were significantly greater after forceps delivery with episiotomy than after spontaneous vaginal delivery (p < 0.01 and p < 0.01). Among the vaginal deliveries, 11 showed laboratory criteria corresponding to blood loss at delivery despite clinical diagnosis in only 2 of them. Unwarranted clinical diagnosis of blood loss at delivery was however made 11 times after vaginal delivery and 19 times after cesarean (20%). CONCLUSION Our findings demonstrate that blood loss during vaginal delivery with episiotomy is greater than during cesarean section and affirms the determining role of forceps use in association with episiotomy in this blood loss. Clinical assessment of blood loss at delivery lacks precision.
Collapse
Affiliation(s)
- R Sarfati
- Service de Gynécologie-Obstétrique, Hôpital Jean-Bernard, Poitiers
| | | | | |
Collapse
|